ArticleCancer immunology, immunotherapy : CII2012

IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients.

B Schilling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.